Key Takeaways
- • Ametek agrees to acquire Indicor's instrumentation division from CD&R for approximately $5 billion in an all-cash transaction, with closing expected in H2 2026.
- • Indicor's instrumentation business generates roughly $1.1 billion in annual revenue and manufactures testing and control equipment for scientific and industrial markets.
- • Ametek plans to finance the deal through a combination of existing credit facilities and newly issued debt, positioning the acquisition as strategically aligned with its portfolio focus amid tariff uncertainty and geopolitical pressures.
- • The transaction reflects Ametek's strong operational momentum, driven by increased demand from power generation projects tied to AI data center expansion, which recently prompted the company to raise its full-year 2026 profit guidance.
Summary
Indicor's instrumentation division develops and manufactures testing and control equipment serving scientific and industrial end markets, with approximately $1.1 billion in annual revenue according to Ametek's figures. The acquisition is expected to close in the second half of 2026, pending customary closing conditions.
Ametek intends to finance the transaction through a combination of borrowings under its existing credit facilities and newly issued debt. The company's acquisition appetite reflects its strong recent performance, particularly benefiting from elevated demand for power generation infrastructure linked to AI data center buildouts. This momentum prompted Ametek to raise its full-year 2026 profit outlook in recent guidance, signaling confidence in both organic growth trajectories and accretive M&A opportunities.
The deal highlights CD&R's exit strategy from Indicor's instrumentation assets while capitalizing on strong demand dynamics in industrial technology markets. For Ametek, the acquisition adds scale in a specialized instrumentation segment while supporting its strategic objective of maintaining focus on higher-growth, mission-critical industrial technology businesses.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.